Finanzas de Nutrien Ltd (NTR)NTRNutrien Ltd

Nutrien Ltd (NTR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Crop nutrients, accounting for 32.8% of total sales, equivalent to $3.54B. Other significant revenue streams include Crop protection products and Seed. Understanding this composition is critical for investors evaluating how NTR navigates market cycles within the Agricultural Chemicals industry.

Evaluating the bottom line, Nutrien Ltd maintains a gross margin of 30.07%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 17.45%, while the net margin is 11.30%. These profitability ratios, combined with a Return on Equity (ROE) of 9.33%, provide a clear picture of how effectively NTR converts its operational activities into shareholder value.

In the context of the broader market, NTR competes directly with industry leaders such as CF and MOS. With a market capitalization of $34.86B, it holds a leading position in the sector. When comparing efficiency, NTR's gross margin of 30.07% stands against CF's 51.44% and MOS's 7.60%. Such benchmarking helps identify whether Nutrien Ltd is trading at a premium or discount relative to its financial performance.

Nutrien's financial performance is robust, with a gross margin of 30.07% in the latest quarter and a forward P/E ratio of 13.986, indicating it is reasonably valued compared to its earnings potential. The company has also shown strong revenue growth, with total revenue reaching $10.81 billion in Q2 2026.